GSK Can't Escape Classen's Patent Infringement Suit
A Maryland federal judge on Tuesday refused to dismiss the bulk of a case against GlaxoSmithKline PLC alleging the pharmaceutical giant infringed Classen Immunotherapies Inc.'s patents for evaluating a vaccine immunization...To view the full article, register now.
Already a subscriber? Click here to view full article